BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2011
View Archived Issues
Nycomed and Orion enter agreement for Easyhaler combination products
Read More
KBP BioSciences presents new dipeptidyl peptidase 4 inhibitors
Read More
Suzhou NeuPharma prepares novel bufalin derivatives
Read More
Novel AMPK activators patented by HanAll BioPharma
Read More
New muscarinic acetylcholine M1 receptor modulators claimed
Read More
Boehringer Ingelheim discloses novel chemokine CXCR3 receptor antagonists
Read More
New antibody protects against both group 1 and 2 influenza A viruses in vivo
Read More
U.S. researchers investigate fasudil for Parkinson's disease
Read More
MDV-3100 blocks breast cancer cell growth in preclinical study
Read More
Sanofi reports on phase III CLEAN study of clopidogrel
Read More
Study compares PreDx Diabetes Risk Score and metabolic syndrome to predict type 2 diabetes incidence
Read More
Acceleron and Celgene enter global collaboration for ACE-536
Read More
Dyax treats first patient in phase II trial of ecallantide
Read More
Phase IIb trial of cell therapy for venous leg ulcers meets endpoints
Read More
Mutations in IRF8 gene correlate with onset of primary immunodeficiencies in humans
Read More
Phase II MILLY trial evaluates lebrikizumab in inadequately controlled asthma
Read More
Promising results reported on Vibex MTX in rheumatoid arthritis
Read More
Prolor Biotech reports encouraging results from phase II hGH-CTP trial
Read More
FDA grants orphan drug status to Kamada's AAT product in type 1 diabetes
Read More
Development of pramlintide/metreleptin for obesity discontinued
Read More
Boehringer Ingelheim obtains E.U. label extension for Pradaxa
Read More
Pitavastatin is approved in Mexico for hyperlipidemia
Read More
First specific treatment for scorpion stings approved in U.S.
Read More
U.S. university evaluates memantine in Down syndrome
Read More